Skip to content
Inciteful Med

Survivorship & Monitoring: Managing Your Long-Term Health

Last updated:

Long-term survivorship in acromegaly depends on achieving biochemical control by keeping IGF-1 and Growth Hormone levels normal. Patients with controlled hormones have a normal life expectancy but require lifelong monitoring for heart health, colon polyps, sleep apnea, and metabolic issues.

Key Takeaways

  • • Achieving normal IGF-1 and Growth Hormone levels restores life expectancy to that of the general population.
  • • Regular echocardiograms are necessary to monitor for acromegalic cardiomyopathy, a condition that causes the heart walls to become thick and stiff.
  • • High IGF-1 levels increase the risk of colonic polyps, requiring more frequent screening colonoscopies.
  • • Patients need ongoing evaluations for related conditions like obstructive sleep apnea, diabetes, and hypertension.
  • • The emotional impact of physical changes from acromegaly is significant, making psychological support a vital part of survivorship.

Receiving a diagnosis and starting treatment for acromegaly is a major milestone, but it is also the beginning of a lifelong commitment to monitoring your health. Because acromegaly is a systemic disease—meaning it affects the whole body—the focus of “survivorship” is ensuring your hormone levels stay controlled and that any related health issues are managed early [1][2].

The Power of Biochemical Control

The most important factor in your long-term outlook is biochemical control. This is defined as having an IGF-1 level that is normal for your age and sex, and keeping your Growth Hormone (GH) levels low (typically below 1.0 μg/L) [3][4].

  • Life Expectancy: Research shows that when acromegaly is uncontrolled, life expectancy can be reduced by up to 10 years [3][5]. However, there is excellent news: if your GH and IGF-1 levels are successfully normalized, your mortality risk returns to that of the general population [3][6].
  • The Importance of Early Control: Because longer diagnostic delays are linked to more health complications, achieving control as quickly as possible is the primary goal of your medical team [5][7].

Managing Your Heart: Acromegalic Cardiomyopathy

The cardiovascular system is often the most impacted by long-term hormone excess [1]. Acromegalic cardiomyopathy is a specific heart condition where the heart walls become thick and stiff (concentric biventricular hypertrophy) [8][9].

  • The Impact: This stiffness can lead to diastolic dysfunction (difficulty with the heart filling with blood) and eventually heart failure if left untreated [8].
  • Monitoring: Even after your hormones are controlled, your heart may not fully “shrink” back to its original size [10]. Regular echocardiograms (heart ultrasounds) are essential to monitor your heart’s structure and function over time [11][12].

Your Long-Term Surveillance Checklist

Ongoing care for acromegaly involves a multidisciplinary approach. You will likely need the following regular screenings:

  1. Biochemical Monitoring: Frequent blood tests to check your IGF-1 levels. This ensures your treatment (whether medication or post-surgery monitoring) is working [13].
  2. Colonoscopies: High levels of IGF-1 are linked to an increased risk of colonic polyps (growths that can become cancerous) [14]. Patients with acromegaly often need more frequent colonoscopies than the general public, starting at the time of diagnosis [14][15].
  3. Sleep Studies: If you were diagnosed with obstructive sleep apnea, you should be re-evaluated after your hormone levels stabilize [1]. While soft tissue swelling may decrease, the apnea can sometimes persist [16].
  4. Metabolic Checks: Regular screening for hypertension and diabetes, as these conditions are highly prevalent and require ongoing management to protect your long-term health [17][1].

The Emotional Toll of Acromegaly

It is crucial to acknowledge the emotional and psychological impact of living with acromegaly. The slow, involuntary changes to your face and body can deeply affect your self-esteem and body image [18]. Even after your hormones are controlled, navigating a changed appearance can be jarring. Validating this grief is an important part of your overall care. Seeking support from a therapist or a patient advocacy group can be just as vital as your physical treatments [18].

While the diagnosis of a chronic condition can be daunting, staying proactive with your monitoring allows you to live a full, healthy life. You are the most important member of your care team, and your engagement in this surveillance schedule is the key to successful survivorship.

Return to Home Page

Frequently Asked Questions

What does biochemical control mean in acromegaly?
Biochemical control means your IGF-1 levels are normal for your age and sex, and your Growth Hormone levels are consistently low. Achieving this control is the most important factor in improving your long-term health and life expectancy.
Will my life expectancy be affected by acromegaly?
If your acromegaly is left uncontrolled, life expectancy can be reduced. However, if your hormone levels are successfully normalized through treatment, your mortality risk returns to that of the general population.
Why do I need regular heart ultrasounds with acromegaly?
Long-term hormone excess can cause acromegalic cardiomyopathy, a condition where the heart walls become thick and stiff. Regular echocardiograms help monitor your heart's structure and function to catch any issues early and prevent heart failure.
Why are frequent colonoscopies recommended for acromegaly patients?
High levels of IGF-1 are linked to an increased risk of colonic polyps, which are growths that can potentially become cancerous. Because of this elevated risk, patients with acromegaly usually need colonoscopies more often than the general public.
Do I still need a CPAP machine after my acromegaly is treated?
While treating acromegaly can reduce soft tissue swelling in your airway, obstructive sleep apnea can sometimes persist even after your hormones are controlled. You should have a follow-up sleep study to determine if you still need to use your CPAP machine.

Questions for Your Doctor

  • • What is my target IGF-1 level, and how often will we test it now that I am in maintenance?
  • • Based on the duration of my illness, how frequently should I have an echocardiogram to check for cardiomyopathy?
  • • Am I due for a colonoscopy, and how does the risk of colonic polyps in acromegaly change my screening schedule?
  • • Now that my hormone levels are controlled, can we re-evaluate my medications for blood pressure or diabetes?
  • • Is my sleep apnea likely to improve with biochemical control, or do I need to continue using my CPAP machine?

Questions for You

  • • Have I kept a log of my IGF-1 results over time to see how my body is responding to treatment?
  • • How is my stamina and breathing during physical activity? Have I noticed any new shortness of breath?
  • • Am I staying consistent with my specialist appointments (endocrinology, cardiology, etc.) even when I feel well?
  • • Do I have a copy of my most recent colonoscopy report to share with my care team?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Acromegaly and it's cardiovascular implications].

    Cadena-Obando DA, Remba-Shapiro I, Abreu-Rosario CG, Mercado M

    Revista medica del Instituto Mexicano del Seguro Social 2021; (59(1)):73-80 doi:10.24875/RMIMSS.M21000054.

    PMID: 33667046
  2. 2

    Updates in rare and not-so-rare complications of acromegaly: focus on respiratory function and quality of life in acromegaly.

    Langlois F, Suarez GM, Fleseriu M

    F1000Research 2020; (9()) doi:10.12688/f1000research.22683.1.

    PMID: 32765836
  3. 3

    Current therapies and mortality in acromegaly.

    Găloiu S, Poiană C

    Journal of medicine and life 2015; (8(4)):411-5.

    PMID: 26664461
  4. 4

    Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center.

    Shen M, Tang Y, Shou X, et al.

    World neurosurgery 2019; (124()):e39-e50 doi:10.1016/j.wneu.2018.11.179.

    PMID: 30500578
  5. 5

    Acromegaly: 'You must know it to think of it'.

    Boguszewski CL

    European journal of endocrinology 2020; (183(1)):C1-C4.

    PMID: 32487776
  6. 6

    A legendary sumo wrestler with gigantism or acromegaly? The case of Ikezuki Geitazaemon (1827-1850).

    Takada K, Sasano M, Hayakawa S

    Medical hypotheses 2020; (144()):110174 doi:10.1016/j.mehy.2020.110174.

    PMID: 33254497
  7. 7

    [Selective screening of patients with associated somatic diseases as a method of early detection of acromegaly].

    Antsiferov MB, Pronin VS, Alekseeva TM, et al.

    Problemy endokrinologii 2021; (67(1)):20-30 doi:10.14341/probl12699.

    PMID: 33586389
  8. 8

    [Cardiovascular complications associated with acromegaly. A state-of-the-art].

    Concepción-Zavaleta M, Muñoz-Moreno J, Quispe-Flores M, et al.

    Archivos de cardiologia de Mexico 2022; (92(4)):513-521 doi:10.24875/ACM.21000339.

    PMID: 35389604
  9. 9

    Cardiovascular Disease in Acromegaly.

    Sharma MD, Nguyen AV, Brown S, Robbins RJ

    Methodist DeBakey cardiovascular journal 2017; (13(2)):64-67 doi:10.14797/mdcj-13-2-64.

    PMID: 28740584
  10. 10

    Alcohol septal ablation in obstructive acromegalic hypertrophic cardiomyopathy - a first case report.

    Viveiros Monteiro A, Fiarresga A, Cacela D, et al.

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2016; (35(9)):499.e1-4.

    PMID: 27503591
  11. 11

    Acromegaly and ultrasound: how, when and why?

    Parolin M, Dassie F, Vettor R, Maffei P

    Journal of endocrinological investigation 2020; (43(3)):279-287 doi:10.1007/s40618-019-01111-9.

    PMID: 31502218
  12. 12

    Aortic root dilation in acromegaly.

    Yeboah-Kordieh YA, Arif W, Weisman D, Salvatori R

    BMJ case reports 2024; (17(7)) doi:10.1136/bcr-2024-260204.

    PMID: 38991564
  13. 13

    Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.

    Falch CM, Dupont AK, Olarescu NC, et al.

    Acta neurochirurgica 2023; (165(10)):3003-3010 doi:10.1007/s00701-023-05772-7.

    PMID: 37665404
  14. 14

    Clinical Characteristics and Associated Factors of Colonic Polyps in Acromegaly.

    Peng G, Li X, Zhou Y, et al.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2022; (130(11)):714-722 doi:10.1055/a-1913-7900.

    PMID: 36075228
  15. 15

    Prospective, Longitudinal Study of Cancer Predictors and Rates in a New York City Cohort of 598 Patients With Acromegaly.

    Freda PU, Bruce JN, Jin Z, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(5)):1247-1257 doi:10.1210/clinem/dgae469.

    PMID: 38986012
  16. 16

    Association of Acromegaly and Central Sleep Apnea Syndrome.

    Pazarlı AC, Köseoğlu Hİ, Kutlutürk F, Gökçe E

    Turkish thoracic journal 2019; (20(2)):157-159 doi:10.5152/TurkThoracJ.2017.17003.

    PMID: 30407161
  17. 17

    Gender differences in the glycometabolic and cardiovascular features of acromegaly.

    Gatto F, Arecco A, De Alcubierre D, et al.

    Pituitary 2026; (29(1)):34 doi:10.1007/s11102-025-01629-7.

    PMID: 41569446
  18. 18

    Acromegaly: clinical features at diagnosis.

    Vilar L, Vilar CF, Lyra R, et al.

    Pituitary 2017; (20(1)):22-32 doi:10.1007/s11102-016-0772-8.

    PMID: 27812777

This page provides educational information about long-term monitoring for acromegaly. Always consult your endocrinologist and broader care team to determine the right surveillance schedule for your specific needs.

Stay up to date

Get notified when new research about Acromegaly is published.

No spam. Unsubscribe anytime.